Menu
  • The Novum Advantage
    • The Difference
    • Case Studies
  • Services
    • Services Overview
    • Scientific Affairs
    • Phase I Early Clinical Development
    • Bioanalytical
    • Biosimilars
    • Phase II-IV Clinical Trial Management
    • Data Management
  • Company
    • Company Overview
    • Mission and Values
    • History
    • Leadership
    • Facility and Features
  • News
  • Careers
    • Careers Overview
    • Open Positions
    • Novum CRA Academy
  • Contact
    • General Inquiries
    • Business Development Inquiries
    • Request a Quote
    • Investigators
    • Employment Opportunities
  • Lambda
  • Participate in a study
  • The Novum Advantage
    • The Difference
    • Case Studies
  • Services
    • Services Overview
    • Scientific Affairs
    • Phase I Early Clinical Development
    • Bioanalytical
    • Biosimilars
    • Phase II-IV Clinical Trial Management
    • Data Management
  • Company
    • Company Overview
    • Mission and Values
    • History
    • Leadership
    • Facility and Features
  • News
  • Careers
    • Careers Overview
    • Open Positions
    • Novum CRA Academy
  • Contact
    • General Inquiries
    • Business Development Inquiries
    • Request a Quote
    • Investigators
    • Employment Opportunities
  • Lambda
  • Participate in a study
News

Novum consolidates American and Canadian Operations

Posted on July 13, 2020 by Todd Westcoat

Novum consolidates American and Canadian Operations

Novum Pharmaceutical Research Services announced today an expansion of its services in North America. Novum, one of the world’s leading Contract Research Organizations (CRO) for almost fifty years, has consolidated Lambda Therapeutic Research’s Toronto, Canada clinic and bioanalytical laboratory into Novum operations. This follows the 2019 acquisition of Novum by Lambda.

The enhanced Novum organization will serve global clients throughout its operations in Pennsylvania, North Dakota, Nevada and Toronto, Canada. The Canadian site, which was founded in 2010, offers additional capacity to provide clinical services including Phase I (First-in-Human), Pharmacokinetics (PK), Pharmacodynamic (PD), Drug-Drug Interaction studies (DDI), Dose Escalation (SAD/MAD), Safety, Tolerability, Dose Ranging, and Patient PK studies.

With state-of-the-art instrumentation, Novum Canada’s bioanalytical lab has developed over 400 assays involving small and large molecules in its GLP compliant facility. Novum Canada’s scientists routinely develop and validate methods and analyze over 15,000 samples a month, including proprietary methods for NCE and generic molecules with sub picogram detection, endogenous, chiral and hormonal assays.

For additional information, prospective customers can visit www.novumprs.com, email Tausif Monif, President, Global Operations at , or email Novum COO Stephanie Finnegan .

About Novum Pharmaceutical Research Services
A leading Contract Research Organization (CRO) since 1972, Novum has been considered one of the world’s leaders in the conduct of clinical trials, from First in Human studies to Late Phase Research requiring patient populations across multiple therapeutic areas. Novum provides bioanalytical services and full-service scientific support in medical writing and statistical analysis. The company is headquartered in Pittsburgh, Pennsylvania with operations in Toronto, North Dakota and Nevada. For more information, visit www.novumprs.com.

 

Share on:
linkedin-icon Created with Sketch.

Categories

  • Blogs
  • Novum News

Archives

225 W. Station Square Drive
Suite 200
Pittsburgh, PA 15219

© 2023, Novum. All rights reserved.Privacy Policy

Site by Imagebox

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.

If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.

OkNo